Literature DB >> 3568450

Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.

A Takeshita.   

Abstract

The distribution and regulatory function of immunoglobulin (Ig) synthesis by monocytes were assessed using several monoclonal antibodies and a cell sorter in samples from 13 patients with multiple myeloma (MM) and nine patients with benign monoclonal gammopathy (BMG). Since all of these cells were separated directly with the cell sorter, their purity and viability were greater than 98% and greater than 99%, respectively. The absolute number of lymphocytes was significantly reduced. The number of monocytes stained with non-specific esterase was within normal range in MM and BMG, as were the absolute number and the proportion of cells which reacted with OKM1 and Mo2 (OKM1+ cells and Mo2+ cells, respectively). The helper activity of monocytes in Ig synthesis stimulated with pokeweed mitogen (PWM) was impaired in MM compared with normal controls. None of these abnormalities in the distribution and regulatory function of monocytes was observed in BMG. The possible immunoregulatory mechanism of MM is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3568450      PMCID: PMC1542457     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro.

Authors:  W Knapp; G Baumgartner
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia.

Authors:  R van Furth; H R Schuit; W Hijmans
Journal:  Br J Haematol       Date:  1966-03       Impact factor: 6.998

3.  Regulation of immunoglobulin synthesis by lymphocytes in multiple myeloma and benign monoclonal gammopathy.

Authors:  A Takeshita
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1986-09

4.  Origin and function of suppressor macrophages in myeloma.

Authors:  J Kennard; S Zolla-Pazner
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

5.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

7.  Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.

Authors:  Y Chen; N Bhoopalam; V Yakulis; P Heller
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

8.  Multiple myeloma: an immunologic profile. Cytotoxic and suppressive effects of the EA rosette-forming cell.

Authors:  T Paglieroni; M R Mackenzie
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

9.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

10.  Hypogammaglobulinemia in experimental myeloma: the role of suppressor factors from mononuclear phagocytes.

Authors:  R S Krakauer; W Strober; T A Waldmann
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

View more
  1 in total

1.  The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors.

Authors:  T Commes; B Klein; M Jourdan; G Clofent; F Houssiau; J Grenier; R Bataille
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.